Mutation of the transforming growth factor-β type II receptor gene is a rare event in human sporadic gastric carcinomas

International Journal of Oncology

Volumn 12, Issue 5, 1998, Pages 1061-1065

  Shitara, Yoshinori ^a,b   Yokozaki, Hiroshi ^a   Yasui, Wataru ^a   Takenoshita, Seiichi ^b   Nagamachi, Yukio ^b   Tahara, Eiichi ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

Gastric carcinoma; Polymorphism; TGF type II receptor

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ARTICLE; CELL DIFFERENTIATION; DNA POLYMORPHISM; DNA SEQUENCE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; INTRON; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; RECEPTOR GENE; SINGLE STRAND CONFORMATION POLYMORPHISM; STOMACH CARCINOMA;

EID: 0031976330     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Roberts AB, Anzano MA, Lamb LC, Smith JM and Sporn MB: New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues. Proc Natl Acad Sci USA 78: 5339-5343, 1981.
2. Moses HL, Yang EY and Pietenpol JA: TGF-β stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 63: 245-247, 1990.
3. Sporn MB, Roberts AB, Wakefield LM and Assoian RK: Transforming growth factor-β: biological function and chemical structure. Science 233: 532-534, 1986.
4. Massagué J: The family of growth and differentiation factors. Cell 49: 437-438, 1987.
5. Cheifetz S, Hernandez H, Laiho M, ten Dijke P, Iwata KK and Massagué J: Distinct transforming growth factor-β (TGF-β) receptor subsets as determinants of cellular responsiveness to three TGF-β isoforms. J Biol Chem 265: 20533-20538, 1990.
6. Derynck R, Goeddel DV, Ullrich A, Gutterman JU, Williams RD, Bringman TS and Berger WH: Synthesis of messenger RNAs for transforming growth factor and the epidermal growth factor receptor by human tumors. Cancer Res 47: 707-712, 1987.
7. Massagué J: Receptors for the TGF-β family. Cell 69: 1067-1070, 1992.
8. Miyazono K, ten Dijke P, Ichijo H and Heldin C-H: Receptors for transforming growth factor-β. Adv Immunol 55: 181-220, 1994.
9. Laiho M, Weis FMB and Massagué J: Concominant loss of transforming growth factor (TGF)-β receptor types I and II in TGF-β-resistant cell mutants implicates both receptor types in signal transduction. J Biol Chem 265: 18518-18524, 1990.
10. López-Casillas F, Cheifetz S, Doody J, Andres JL, Lane WS and Massagué J: Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-β receptor system. Cell 67: 785-795, 1991.
11. Franzén P, ten Dijke P, Ichijo H, Yamashita H, Schools P, Heldin C-H and Miyazono K: Cloning of a TGFB type I receptor that forms a heteromeric complex with the TGFB type II receptor. Cell 75: 681-692, 1993.
12. Yamashita H, ten Dijke P, Franzén P, Miyazono K and Heldin C-H: Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-β. J Biol Chem 269: 20172-20178, 1994.
13. Wrana JL, Attisano L, Wieser R, Ventura F and Massagué J: Mechanism of activation of TGFβ receptor. Nature 370: 341-347, 1994.
14. Yoshida K, Yokozaki H, Niimoto M, Ito H, Ito M and Tahara E: Expression of TGF-beta and procollagen type I and type III in human gastric carcinomas. Int J Cancer 44: 394-398, 1989.
15. Ito M, Yasui W, Kyo E, Yokozaki H, Nakayama H, Ito H and Tahara E: Growth inhibition of transforming growth factor B on human gastric carcinoma cells: receptor and postreceptor signaling. Cancer Res 52: 295-300, 1992.
16. Ito M, Yasui W, Nakayama H, Yokozaki H, Ito H and Tahara E: Reduced levels of transforming growth factor-beta type I receptor in human gastric carcinomas. Jpn J Cancer Res 83: 86-92, 1992.
17. Park K, Kim S-J, Bang Y-J, Park J-G, Kim NK, Roberts AB and Sporn MB: Genetic change in the transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-β. Proc Natl Acad Sci USA 91: 8772-8776, 1994.
18. Sun L, Wu G, Willson JKV, Zborowska E, Yang J, Rajkarunanayake I, Wang J, Gentry LE, Wang X-F and Brattain MG: Expression of transforming growth factor β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. J Biol Chem 269: 26449-26455, 1994.
19. Wang J, Sun L, Myeroff L, Wang X, Gentry LE, Yang J, Liang J, Zborowska E, Markowitz S, Willson JKV and Brattain MG: Demonstration that mutation of the type II transforming growth factor β receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells. J Biol Chem 270: 22044-22049, 1995.
20. Kim IY, Ahn H-J, Zelner DJ, Shaw JW, Sensibar JA, Kim J-H, Kato M and Lee C: Genetic change in transforming growth factor β (TGF-β) receptor type I gene correlates with insensitivity to TGF-β1 in human prostate cancer cells. Cancer Res 56: 44-48, 1996.
21. Chang J, Park K, Bang Y-J, Kim WS, Kim D and Kim S-J: Expression of transforming growth factor β type II receptor reduces tumorigenicity in human gastric cancer cells. Cancer Res 57: 2856-2859, 1997.
22. Lu S-L, Akiyama Y, Nagasaki H, Saito K and Yuasa Y: Mutations of the transforming growth factor-β type II receptor gene and genomic instability in hereditary nonpolyposis colorectal cancer. Biochem Biophys Res Commun 216: 452-457, 1995.
23. Parsons R, Myeroff LL, Liu B, Willson JKV, Markowitz S, Kinzler KW and Vogelstein B: Microsatellite instability and mutations of the transforming growth factor β type II receptor gene in colorectal cancer. Cancer Res 55: 5548-5550, 1995.
24. Markowitz S, Wang J, Myeroff LL, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B, Brattain M and Willson JKV: Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 268: 1336-1338, 1995.
25. Myeroff LL, Parsons R, Kim S-J, Hedrick L, Cho KR, Orth K, Mathis M, Kinzler KW, Lutterbaugh J, Park K, Bang Y-J, Lee H, Park J-G, Lynch HT, Roberts AB, Vogelstein B and Markowitz SD: A transforming growth factor β receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res 55: 5545-5547, 1995.
26. Takenoshita S, Hagiwara K, Nagashima M, Gemma A, Bennett WP and Harris CC: The genomic structure of the gene encoding the human transforming growth factor β type II receptor (TGF-β RII). Genomics 36: 341-344, 1996.
27. Lu S-L, Zhang W-C, Akiyama Y, Nomizu T and Yuasa Y: Genomic structure of the transforming growth factor β type II receptor gene and its mutations in hereditary nonpolyposis colorectal cancers. Cancer Res 56: 4595-4598, 1996.
28. Takenoshita S, Tani M, Nagashima M, Hagiwara K, Bennett WP, Yokota J and Harris CC: Mutation analysis of coding sequences of the entire transforming growth factor beta type II receptor gene in sporadic human colon cancer using genomic DNA and intron primers. Oncogene 14: 1255-1258, 1997.
29. Vincent F, Nagashima M, Takenoshita S, Khan MA, Gemma A, Hagiwara K and Bennett WP: Mutation analysis of the transforming growth factor-β type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-β. Oncogene 15: 117-122, 1997.
30. Ochiai A, Yasui W and Tahara E: Growth-promoting effect of gastrin on human gastric carcinoma cell line TMK-1. Jpn J Cancer Res 76: 1064-1071, 1985.
31. Yanagihara K, Seyama T, Tsumuraya M, Kamada N and Yokoro K: Establishment and characterization of human signet ring cell gastric carcinoma cell lines with amplification of the c-myc oncogene. Cancer Res 51: 381-386, 1991.
32. Sano T, Tsujino T, Yoshida K, Nakayama H, Haruma K, Ito H, Nakamura Y, Kajiyama G and Tahara E: Frequent loss of heterozygosity on chromosome 1q, 5q, and 17p. Cancer Res 51: 2926-2931, 1991.
33. Togo G, Toda N, Kanai F, Kato N, Shiratori Y, Kishi K, Imazeki F, Makuuchi M and Omata M: A transforming growth factor β type II receptor gene mutation common in sporadic cecum cancer with microsatellite instability. Cancer Res 56: 5620-5623, 1996.
34. Ohue M, Tomita N, Monden T, Miyoshi Y, Ohnishi T, Izawa H, Kawabata Y, Sasaki M, Sekimoto M, Nishisho I, Shiozaki H and Monden M: Mutations of the transforming growth factor β type II receptor gene and microsatellite instability in gastric cancer. Int J Cancer 68: 203-206, 1996.
35. Garrigue-Antar L, Muñoz-Antonia T, Antonia SJ, Gesmonde J, Vellucci VF and Reiss M: Missense mutations of the trans-forming growth factor β type II receptor in human head and neck squamous carcinoma cells. Cancer Res 55: 3982-3987, 1995.
36. Ionov Y, Peinado MA, Malkhosyan S, Shibata D and Perucho M: Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363: 558-561, 1993.
37. Leach FS, Nicolaides NC, Papadopoulos N, Liu B, Jen J, Parsons R, Peltomäki P, Sistonen P, Aaltonen LA, Nyström-Lahti M, Guan X-Y, Zhang J, Meltzer PS, Yu J-W, Kao F-T, Chen DJ, Cerosaletti KM, Fournier REK, Todd S, Lewis T, Leach RJ, Naylor SL, Weissenbach J, Mecklin J-P, Järvinen H, Petersen GM, Hamilton SR, Green J, Jass J, Watson P, Lynch HT, Trent JM, Chapelle A, Kinzler KW and Vogelstein B: Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75: 1215-1225, 1993.
38. Fishel R, Lescoe MK, Rao MRS, Copeland NG, Jenkins NA, Garber J, Kane M and Kolodner R: The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75: 1027-1038, 1993.
39. + tumor cells. Cell 75: 1227-1236, 1993.
40. Liu B, Nicolaides NC, Markowitz S, Willson JKV, Parsons RE, Jen J, Papadopolous N, Peltomäki P, de la Chapelle A, Hamilton SR, Kinzler KW and Vogelstein B: Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat Genet 9: 48-55, 1995.
41. Marra G and Boland CR: Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives. J Natl Cancer Inst 87: 1114-1125, 1995.
42. Rhyu MS: Molecular mechanisms underlying hereditary nonpolyposis colorectal carcinoma. J Natl Cancer Inst 88: 240-251, 1996.
43. Semba S, Yokozaki H, Yamamoto S, Yasui W and Tahara E: Microsatellite instability in precancerous lesions and adenocarcinomas of the stomach. Cancer 77: 1620-1627, 1996.
44. Han H-J, Yanagisawa A, Kato Y, Park J-G and Nakamura Y: Genetic instability in pancreatic cancer and poorly differentiated type of gastric cancer. Cancer Res 53: 5087-5089, 1993.
45. Rhyu M-G, Park W-S and Melzer SJ: Microsatellite instability occurs frequently in human gastric carcinoma. Oncogene 9:29-32, 1994.
46. Strickler JG, Zheng J, Shu Q, Burgart LJ, Alberts SR and Shibata D: p53 mutations and microsatellite instability in sporadic gastric cancer: when guardians fail. Cancer Res 54: 4750-4755, 1994.
47. Garrigue-Antar L, Souza RF, Vellucci VF, Meltzer SJ and Reiss M: Loss of transforming growth factor-β type II receptor gene expression in primary human esophageal cancer. Lab Invest 75: 263-272, 1996.
48. Bae HW, Geiser AG, Kim DH, Chung MT, Burmester JK, Sporn MB, Roberts AB and Kim SJ: Characterization of the promoter region of the human transforming growth factor-β type II receptor gene. J Biol Chem 270: 29460-29468, 1995.
49. Muñoz-Antonia T, Li X, Reiss M, Jackson R and Antonia S: A mutation in the transforming growth factor β type II receptor gene promoter associated with loss of gene expression. Cancer Res 56: 4831-4835, 1996.